Skip to Main Content

Paper Details

Developing a Continuous Severity Scale for Macular Telangiectasia Type 2 Using Deep Learning and Implications for Disease Grading.
Ophthalmology
1
2024
MacTel, MacTel disease, Macular Telangiectasia Type 2, macular telangiectasia, participants, patient
Author NameAffiliation
Yue WuUniversity of Washington
Catherine EganMoorfields Eye Hospital, United Kingdom University College London, Institute of Ophthalmology
Abraham Olvera-BarriosMoorfields Eye Hospital, United Kingdom University College London, Institute of Ophthalmology
Lea ScheppkeLowy Medical Research Institute, California The Scripps Research Institute
Tunde PetoCenter for Public Health, Queen's University Belfast
Peter Charbel IssaOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, University of Oxford
Tjebo F C HeerenMoorfields Eye Hospital
Irene LeungMoorfields Eye Hospital
Anand E RajeshUniversity of Washington
Adnan TufailMoorfields Eye Hospital, United Kingdom University College London, Institute of Ophthalmology
Cecilia S LeeUniversity of Washington
Emily Y ChewDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
Martin FriedlanderLowy Medical Research Institute, California The Scripps Research Institute
Aaron LeeUniversity of Washington
  • 1 - 14

Datasets